Caberos 0.125 - Driada Medical

First developed in the 1980s, Cabergoline has gained widespread international use for its selective action on prolactin inhibition, sold under Dostinex and other brand names. It is commonly administered in tablet form, with dosing carefully controlled to avoid prolactin over-suppression or unnecessary side effects. Its primary role is in conditions marked by excessive prolactin levels, like prolactinomas, where it helps restore hormonal balance. In addition to prolactin suppression, its effect on D2 receptors extends its utility to selective symptoms of dopamine deficiency disorders, such as Parkinson’s disease​​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Caberos 0.125 by Driada Medical, consult with your doctor or healthcare professional.